Adamis Pharmaceuticals Corp
NASDAQ:ADMP
Income Statement
Earnings Waterfall
Adamis Pharmaceuticals Corp
Revenue
|
4.8m
USD
|
Cost of Revenue
|
-6.2m
USD
|
Gross Profit
|
-1.4m
USD
|
Operating Expenses
|
-23.6m
USD
|
Operating Income
|
-25.1m
USD
|
Other Expenses
|
-1.4m
USD
|
Net Income
|
-26.5m
USD
|
Income Statement
Adamis Pharmaceuticals Corp
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
3
N/A
|
2
-20%
|
5
+115%
|
|
Gross Profit | ||||
Cost of Revenue |
(6)
|
(7)
|
(6)
|
|
Gross Profit |
(4)
N/A
|
(5)
-31%
|
(1)
+69%
|
|
Operating Income | ||||
Operating Expenses |
(28)
|
(27)
|
(24)
|
|
Selling, General & Administrative |
(20)
|
(16)
|
(13)
|
|
Research & Development |
(8)
|
(11)
|
(10)
|
|
Operating Income |
(32)
N/A
|
(32)
-1%
|
(25)
+22%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
0
|
(8)
|
0
|
|
Non-Reccuring Items |
(5)
|
5
|
(1)
|
|
Pre-Tax Income |
(36)
N/A
|
(35)
+3%
|
(26)
+24%
|
|
Net Income | ||||
Tax Provision |
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(36)
|
(35)
|
(26)
|
|
Net Income (Common) |
(49)
N/A
|
(46)
+7%
|
(26)
+42%
|
|
EPS (Diluted) |
-44.55
N/A
|
-22.24
+50%
|
-12.36
+44%
|